US 11384154
Targeted chimeric proteins and uses thereof
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 11384154 (Targeted chimeric proteins and uses thereof) held by Orionis Biosciences, Inc expires Mon Jul 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Orionis Biosciences, Inc
- Grant date
- Tue Jul 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61P, A61P1/16